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Abstract 
During cytokinesis in eukaryotic cells, an actomyosin-based contractile ring (CR) is 
assembled along the equator of the cell. Myosin II ATPase activity is stimulated by the 
phosphorylation of the myosin II regulatory light chain (MRLC) in vitro, and 
phosphorylated MRLC localizes at the CR in various types of cells. Previous studies 
have determined that phosphorylated MRLC plays an important role in CR furrowing. 
However, the role of phosphorylated MRLC in CR assembly remains unknown. Here, 
we have used confocal microscopy to observe dividing HeLa cells expressing 
fluorescent protein-tagged MRLC mutants and actin during CR assembly near the 
cortex. Di-phosphomimic MRLC accumulated at the cell equator earlier than 
non-phosphorylatable MRLC and actin. Interestingly, perturbation of myosin II activity 
by non-phosphorylatable MRLC expression or treatment with blebbistatin, a myosin II 
inhibitor, did not alter the time of actin accumulation at the cell equator. Furthermore, 
inhibition of actin polymerization by treatment with latrunculin A had no effect on 
MRLC accumulation at the cell equator. Taken together, these data suggest that 
phosphorylated MRLC temporally controls its own accumulation, but not that of actin, 
in cultured mammalian cells. 
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Introduction 
The contractile ring (CR), which mainly consists of filamentous actin (F-actin) and 
myosin II, is formed at the equator of a cell. During cytokinesis in eukaryotic cells, the 
CR undergoes constriction to form a cleavage furrow. A pivotal study has shown that 
the furrowing occurs between centrosomes linked by mitotic spindles [1], suggesting 
that a signal from the mitotic apparatus determines the position of the cleavage furrow. 
It was subsequently revealed that the small GTPase Rho is the positional cue for the CR 
assembly at the cell equator [2, 3], and a midzone-localizing complex containing 
MKLP1, MgcRacGAP, and ECT2 is required for Rho activation during cytokinesis 
[4-7]. Although recent advances in functional genomics and proteomics have aided in 
understanding the molecular requirements of cytokinesis in eukaryotic cells [8, 9], it 
remains unclear how cytokinetic proteins such as F-actin and myosin II cooperate in CR 
assembly and constriction. 
Myosin II, which is composed of three distinct types of subunits [heavy chain 
(MHC), essential light chain, and regulatory light chain (MRLC)], has been shown to be 
essential for invagination of the cleavage furrow in various cell lines [10-13]. 
Phosphorylation of MRLC at Ser19 (monophosphorylation) and at Thr18 and Ser19 
(diphosphorylation) causes myosin II activation and the assembly of bipolar filaments in 
vitro [14, 15]. Phosphorylated and nonphosphorylated MRLC localize to the CR during 
cytokinesis in mammalian cells [16-21]. Our recent studies have shown that the 
phosphorylation of MRLC controls the dynamics of myosin II and actin at the CR, 
resulting in the proper speed of furrow ingression [22, 23]. In combination, these data 
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indicate that phosphorylated MRLC plays an important role in CR constriction in 
mammalian cells. However, its role in CR assembly remains unknown. 
In this study, to clarify the role of phosphorylated MRLC in CR assembly, we 
observed equatorial MRLC and actin accumulation by using fluorescent protein-tagged 
phosphomimic (AD- and DD-) or non-phosphorylatable (AA-) MRLC and actin during 
cytokinesis in dividing HeLa cells. Di-phosphomimic MRLC (DD-MRLC) accumulated 
at the cell equator earlier than non-phosphorylatable MRLC (AA-MRLC) and actin. 
Perturbation of myosin II activity had no effect on the time of actin accumulation at the 
equatorial region. Furthermore, the time of MRLC accumulation was not altered by 
inhibition of actin polymerization. Taken together, these data suggest that the 
phosphorylation of MRLC regulates its own accumulation, but not that of actin, at the 
CR during cytokinesis in mammalian cells. 
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Materials and Methods 
 
Reagents and chemicals 
Mouse anti-MRLC antibody (E-4) and rabbit Living Colors A.v. Peptide Antibody were 
obtained from Santa Cruz Biotechnology (Santa Cruz, CA, USA) and Clontech 
Laboratories (Palo Alto, CA, USA), respectively. S-(–)-Blebbistatin and latrunculin A 
were obtained from Toronto Research Chemicals (Ontario, Canada) and Wako Pure 
Chemical Industries (Osaka, Japan), respectively. Rabbit anti-MHC antibody was a kind 
gift from Dr. K. Fujiwara (University of Rochester, Rochester, NY, USA). 
 
Plasmid construction 
The pmCherry vector and p-enhanced green fluorescent protein (EGFP)-actin were 
obtained from Clontech Laboratories. cDNA encoding AA/AD/DD-MRLC, in which 
Thr18 and Ser19 are each replaced by Ala and/or Thr [18], were inserted into 
pmCherry-N1. The construction of pmCherry-wild type (Wt)-MRLC or actin have been 
previously described [23]. 
 
Cell culture and plasmid transfection 
HeLa cells (RCB0007) were obtained from the RIKEN Cell Bank (Tsukuba, Japan). 
The cells were cultured as previously described [23]. Transfection of plasmids was 
performed using Lipofectamine (Invitrogen, Carlsbad, CA, USA), according to the 
manufacturer’s instructions. 
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Immunoprecipitation and western blotting 
HeLa cells expressing mCherry-MRLCs, EGFP-DD-MRLC, or mCherry were collected 
with a rubber policeman in RIPA buffer [50 mM Tris-HCl (pH 7.5), 150 mM NaCl, 
0.1% SDS, 1% Nonidet P-40, 0.5% deoxycholate, 1 mM EGTA, 1 mM PMSF, 1 g/mL 
pepstatin A, and 10 mM MgCl2]. The mixture was sonicated twice on ice with a 
Branson Sonifier 450 at 10-s pulses (60% duty cycle) at a setting of 3, and centrifuged 
at 15,100 ×g for 30 min at 4°C, and the supernatant (lysate) was collected. For 
immunoprecipitation, the lysate was incubated with Living Colors A.v. Peptide 
Antibody (1 g) for 1 h at 4°C, and then gently agitated with Protein G Sepharose (GE 
Healthcare Japan, Tokyo, Japan) for 1 h at 4°C. The beads were collected by 
centrifugation (700 ×g), washed three times with RIPA buffer, and then added to SDS 
sample buffer. The samples were subjected to SDS-PAGE using a gradient gel 
(MULTIGEL II Mini 4/20; Cosmo Bio, Tokyo, Japan) and transferred to 
Immobilon-PSQ transfer membranes (pore size, 0.2 m; Millipore, Billerica, MA, 
USA). The membranes were incubated with anti-MHC antibody (1:100) or anti-MRLC 
antibody (1:100) for 1 h at room temperature, and were then incubated with alkaline 
phosphatase-conjugated secondary antibodies (1:5,000) (Promega KK, Tokyo, Japan) 
for 1 h at room temperature. The blots were developed with 0.2 mg/mL nitroblue 
tetrazolium and 0.1 mg/mL 5-bromo-4-chloro-3-indolyl phosphate (Nacalai Tesque, 
Kyoto, Japan). 
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Indirect immunofluorescence 
HeLa cells were transfected with pmCherry-MRLC and pEGFP-actin and fixed with 
3.7% formaldehyde. After washing with PBS [23], the cells were mounted on a 
microscope slide with a drop of FluoroGuard (Bio-Rad Laboratories, Hercules, CA, 
USA) containing 0.5 g/mL 4,6-diamidine-2-phenylindole dihydrochloride (DAPI). To 
investigate the effect of actin polymerization, HeLa cells were treated with latrunculin 
A (100 nM) or DMSO for 10 or 30 min at 37°C. The cells were stained using 
TRITC-phalloidin (Sigma-Aldrich, St. Louis, MO, USA) for F-actin analysis as 
previously described [23]. Images were obtained using a FV1000-D confocal laser 
scanning microscope (Olympus, Tokyo, Japan) with a UPLSAPO 100× NA 1.4 oil 
immersion lens (Olympus). Images were processed using FluoView software (Olympus) 
and Adobe Photoshop. 
 
Live cell imaging 
To investigate the inhibition of CR furrowing by blebbistatin, cells were treated with 1 
or 25 M blebbistatin or DMSO for 2 h, and images were obtained using a FV1000-D 
microscope with a UPLSAPO 20× NA 0.75 dry lens (Olympus) and a 559-nm laser to 
avoid phototoxicity and photoinactivation of blebbistatin [24, 25]. To obtain images of 
fluorescent protein-tagged MRLCs and actin during CR assembly, we observed the area 
near the bottom of the cells as 1-m step z-series using the FV1000-D microscope with 
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a UPLSAPO 100× (NA, 1.4) oil immersion lens. To observe CR assembly in the 
presence of blebbistatin, cells in the anaphase were treated with 25 M blebbistatin or 
DMSO, and images were obtained. The diameter of the CR was measured using 
FluoView software. For observation of cells in the presence of latrunculin A, cells in the 
metaphase were treated with 100 nM latrunculin A or DMSO and observed for 6 h. 
Fluorescence measurements and image processing were performed with FluoView 
software and Adobe Photoshop, respectively. The accumulation time of MRLC or actin 
was defined as the period (min) from the onset of anaphase to the time when the relative 
fluorescence intensity value at the cell equator exceeded 1.05. Statistical analysis was 
performed using the Student’s t-test and the Pearson’s correlation test. We confirmed 
that irradiation of the laser did not affect the progress of cytokinesis, including the speed 
of CR furrowing (data not shown).
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Results 
Characterization of mCherry-tagged MRLC mutants 
To characterize the four mCherry-tagged MRLC mutant variants 
(Wt/AA/AD/DD-MRLC), we examined their physical accessibility to MHC in cells by 
immunoprecipitation using Living Colors A.v. Peptide Antibody. Endogenous MHC 
was coimmunoprecipitated with mCherry-tagged MRLC mutants from HeLa cell 
lysates (Fig. 1A). This was in agreement with the previous result obtained with 
EGFP-tagged MRLC mutants [26]. We also found that although MRLC-mCherry was 
immunoprecipitated in equal amounts, MHC was coprecipitated in smaller amounts 
from the lysate of DD-MRLC than that of Wt-, AA-, or AD-MRLC (Fig. 1A). 
EGFP-tagged MRLC has been shown to have the same turnover rate on MHC IIA in 
stress fibers and CR [23], suggesting that mCherry-tagged MRLC mutants also bind to 
the MHC and localize at the contractile apparatus such as the stress fibers or the CR in 
cells. Next, we observed the subcellular localization of DD-MRLC-mCherry as a 
representative of MRLC mutants. DD-MRLC-mCherry was colocalized with 
EGFP-actin in the interphasic (Fig. 1B, upper) and mitotic cells (Fig. 1B, lower). These 
data indicate that mCherry-tagged MRLC mutants can act as a myosin II subunit in cells, 
similar to EGFP-tagged mutants. 
 
Phosphorylated MRLC accumulated at the cell equator earlier than 
nonphosphorylated MRLC 
To determine whether the phosphorylation of MRLC regulates its accumulation at the 
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cell equator, we used confocal microscopy to observe the region near the bottom of the 
cortex in the dividing cells expressing AA- or DD-MRLC-mCherry (Fig. 2A). The time 
of MRLC accumulation at the cell equator had no correlation with its expression level 
(Fig. 2B). AA-MRLC was recruited 4.6 ± 0.4 min after the onset of anaphase, whereas 
DD-MRLC accumulated at 2.7 ± 0.3 min (Fig. 2C). These data indicate that the 
phosphorylation of MRLC accelerated its accumulation at the equatorial region of cells. 
 
MRLC accumulated at the cell equator before actin  
To examine whether phosphorylated MRLC controls CR assembly, each 
mCherry-tagged MRLC mutant was coexpressed with EGFP-actin in HeLa cells (Fig. 
3A and 3D). The time of MRLC accumulation at the cell equator had no correlation 
with the EGFP-actin expression level (Fig. 3B) or MRLC itself (Fig. S1A). As shown in 
Figure 3C, the time of AA-MRLC-mCherry accumulation (5.0 ± 0.7 min after the onset 
of anaphase) at the cell equator of cells coexpressing EGFP-actin was significantly 
delayed compared with that of DD-MRLC-mCherry (3.0 ± 0.5 min), which was 
consistent with the results obtained in Figure 2. The time of EGFP-actin accumulation at 
the equator in the cells coexpressing each mCherry-tagged MRLC mutant did not 
correlate with the MRLC mutant expression levels (Fig. 3E) or with EGFP-actin itself 
(Fig. S1B). Interestingly, the expression of each MRLC mutant did not affect the time of 
EGFP-actin accumulation at the equator (Fig. 3F), suggesting that actin accumulation at 
the equator was independent of MRLC and its phosphorylation state. The differences in 
the accumulation time between MRLC and actin in the cells expressing Wt-, AD-, and 
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DD-MRLC were 0.7–1.7 min, whereas the differences in the cells expressing 
AA-MRLC was just 0.1 min (Fig. 3G). These data indicate that the time of actin 
accumulation at the cell equator was independent of MRLC, and MRLC accumulated at 
the cell equator earlier than actin in HeLa cells. 
 
Myosin II ATPase activity was not required for actin accumulation at the cell 
equator 
Next, we determined whether the accumulation of actin at the cell equator was 
independent of myosin II ATPase activity. Treatment with blebbistatin (25 M), a 
myosin II inhibitor, significantly delayed the speed of CR contraction, but did not 
inhibit the completion of CR furrowing (Fig. 4A). These data suggest that treatment 
with blebbistatin (25 M) was optimal to mimic the phenotype of 
AA-MRLC-expressing cells that only exhibit a delay in CR furrowing [22]. Cells 
expressing mCherry-actin were treated with blebbistatin, and then, observed (Fig. 4B). 
Accumulation of mCherry-actin at the cell equator did not correlate with its expression 
level (Fig. 4C), and blebbistatin did not alter the time of actin accumulation (Fig. 4D). 
These data indicate that myosin II ATPase activity was not crucial for actin 
accumulation at the cell equator. 
 
MRLC accumulation at the cell equator was independent of actin accumulation 
To further investigate the interaction between MRLC and actin during CR assembly, we 
observed cells treated with 100 nM latrunculin A, an inhibitor of actin polymerization. 
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Accumulation of F-actin at the equator was disrupted by latrunculin A (Fig. 5A). We 
further observed Wt-MRLC-mCherry accumulation in cells treated with 100 nM 
latrunculin A (Fig. 5B). The time of Wt-MRLC-mCherry accumulation was unaffected 
by its expression level (Fig. 5C). As shown in Figure 5D, latrunculin A had no effect on 
Wt-MRLC accumulation at the cell equator. These data suggest that MRLC 
accumulation at the cell equator was independent of actin accumulation.
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Discussion 
Our previous living cell-imaging studies revealed that both the phosphomimic and 
non-phosphorylatable forms of EGFP-MRLC were recruited to the equator [21]. The 
data obtained using mCherry-MRLCs supported these results, suggesting that 
phosphorylation of MRLC is not essential for recruitment of MRLC to the equator. In 
this study, the data obtained using a highly sensitive confocal microscope indicated that 
the non-phosphorylatable MRLC accumulated at the equator later than the 
phosphomimic MRLC did. Further, phosphomimic mutants of MRLC and blebbistatin 
treatment did not affect the timing of actin accumulation at the equator. These data 
suggest that myosin II activity is not required for recruitment of actin at the equator 
during cytokinesis. 
The accumulation of MHC and actin at the cell equator has been observed in fixed 
budding yeast [27] and Xenopus eggs [28], and in living fission yeast [29] and cultured 
animal cells [30]. These studies concluded that equatorial MHC accumulation precedes 
actin accumulation. In fixed Drosophila S2 cells stably expressing MRLC, enrichment 
of MRLC at the cell equator was also observed earlier than that of F-actin. In these 
studies, however, real-time imaging of the accumulation of MHC and/or MRLC in the 
cells coexpressing actin was not performed. As such, we performed real-time imaging 
of both MHC/MRLC and actin at the equatorial cortex within the same system. Here, 
our real-time imaging studies using confocal microscope revealed that MRLC 
accumulation at the cell equator occurred earlier than actin accumulation in cultured 
mammalian cells co-expressing MRLC and actin. These data show that equatorial 
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accumulation of MHC/MRLC before actin is a fundamental mechanism of CR assembly 
in various types of eukaryotic cells. 
An important issue is the cellular mechanism by which MHC/MRLC is recruited to 
the cell equator before actin. One potential regulator for assembling proteins such as 
actin and myosin II at the CR is Mid1/anillin in eukaryotes [31-35]. According to one of 
the two present models in Schizosaccharomyces pombe, Mid1 recruits MHC, an 
IQ-motif-containing GTPase activating protein, formin, and Cdc15 to the equator, and 
then F-actin emanated from a formin(s), forms the CR [36, 37]. On the contrary, a 
Mid1-independent model for CR assembly has also been proposed [32, 38]. In animal 
cells, MHC was recruited to the cell cortex in anillin-depleted cultured Drosophila 
Kc167 and mammalian cells [39, 40], although anillin has been reported to be a MHC- 
or MRLC-interacting protein [39]. Thus, the precise role of Mid1/anillin in CR 
assembly is highly controversial. 
Another candidate as an essential protein for CR assembly is the 
actin/MHC-interacting protein septin [41-44]. MHC accumulation at the cell equator 
was not observed in the septin mutant Saccharomyces cerevisiae strain [27]. Although 
the transduction of a truncated MHC coiled-coil domain into the CHO-K1 cells 
inhibited the interaction between mammalian septin SEPT2 and MHC-IIA, initial 
accumulation of MHC-IIA at the cell equator was not altered, even in cells transfected 
with the domain [43], suggesting that factor(s) other than septin are required for the 
recruitment of MHC to the equator. Thus, the role of septin in the recruitment of 
MHC/MRLC to the cell equator is also controversial. 
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To date, there are several hypotheses, which are not mutually exclusive, of how 
MHC/MRLC is accumulated at the equator, such as the cortical flow hypothesis [45, 46]. 
Although this hypothesis has been supported by the imaging of membrane-bound beads 
[47], GFP-MHC [48], and myosin II itself [49], recent observations with total internal 
reflection fluorescence microscopy have revealed that MHC is recruited to the equator 
through a cortical flow-independent mechanism [30, 50]. Uyeda et al. indicated that a 
conformational change in actin subunits promotes the binding of myosin II [51]. 
Interestingly, local tension at the cell equator has been reported to increase after cell 
elongation to the poles [52]. Such tension at the cell equator will cause a conformational 
change in cortical actin and induce myosin II accumulation at the cell equator. Thus, we 
propose a mechanism for equatorial myosin II accumulation (Fig. 6). As shown in 
Figures 2 and 3, phosphorylated MRLC preferentially accumulates at the cell equator 
before the onset of anaphase (Fig. 6a and 6b), although its mechanism has not been 
elucidated. Accumulated MRLC causes an increase of cortical tension, because of the 
interaction with the preexisting F-actin beneath the cell membrane at the cell equator 
(Fig. 6c). Subsequently, more MRLC accumulates at the equator (Fig. 6d). Then, actin 
accumulates more effectively at the cell equator (Fig. 6e), which is followed by CR 
constriction. 
Our recent study showed that diphosphorylated MRLC localized to the midzone 
independently of MHC during cytokinesis in various mammalian cultured cells [53]. 
Naqvi et al. reported that MRLC (cdc4p and Rlc1p) localized to the cell equator 
independent of MHC (Myo2p) in Schizosaccharomyces pombe [54, 55]. These results 
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suggest that a subpopulation of MRLC works without MHC. Future studies are required 
for additional imaging and biochemical analysis to elucidate the role of MHC-unbound 
MRLC and/or MRLC-unbound MHC in cytokinesis. 
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Figure captions 
Figure 1. Characterization of MRLC-mCherry mutants  
(A) Western blots of immunoprecipitates from HeLa cell lysates with Living Colors A.v. 
Peptide Antibody. Cells were transfected with the indicated plasmids. Myosin HC; 
myosin heavy chain. (B) HeLa cells expressing DD-MRLC-mCherry and EGFP-actin 
were fixed and counterstained with DAPI. Cells were observed by confocal microscopy. 
Bar, 10 μm. 
 
Figure 2. Phosphorylated MRLC is recruited to the cell equator earlier than 
nonphosphorylated MRLC.  
(A) HeLa cells expressing AA- or DD-MRLC-mCherry. Anaphase onset is designated 
as time 0. Bar, 10 m. (B) The fluorescent intensity of AA- or DD-MRLC-mCherry at 
the equator (x-axis) and each accumulation time (y-axis) were plotted. (C) The average 
time of MRLC accumulation in cells (n ≥ 7) expressing AA- or DD-MRLC-mCherry 
are indicated. **p < 0.01 (Student’s t-test). 
 
Figure 3. MRLC is recruited to the cell equator earlier than actin, and the 
recruitment is independent of its phosphorylation state.  
(A) HeLa cells coexpressing MRLC-mCherry and EGFP-actin. Anaphase onset is 
designated as time 0. Bar, 10 m. (B) The fluorescent intensity of Wt-, AA-, AD-, or 
DD-MRLC-mCherry at the equator (x-axis) and each accumulation time (y-axis) were 
plotted in the cells coexpressing EGFP-actin. (C) The average accumulation time of 
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each MRLC mutant at the cell equator (n ≥ 6). *p < 0.05 (Student’s t-test). (D) HeLa 
cells coexpressing MRLC-mCherry and EGFP-actin. Anaphase onset was designated as 
time 0. Bar, 10 m. (E) The fluorescent intensity of EGFP-actin at the equator (x-axis) 
and each accumulation time (y-axis) were plotted in the cells expressing Wt-, AA-, AD-, 
or DD-MRLC-mCherry. (F) The average time of mCherry-actin accumulation at the 
equator in cells (n ≥ 6) expressing each MRLC mutants. (G) The average accumulation 
time of each mCherry-tagged MRLC mutant and EGFP-actin are shown in (C) and (F). 
*p < 0.05 (Student’s t-test). 
 
Figure 4. Inhibition of myosin II ATPase activity did not alter the time of actin 
accumulation at the cell equator.  
(A) The effect of blebbistatin on the speed of furrow ingression in dividing HeLa cells 
(n ≥ 4). The half-time (t1/2) of furrow ingression is shown in the inset. *p < 0.05 
(Student’s t-test). (B) HeLa cells expressing mCherry-actin in the presence of DMSO 
(control) or blebbistatin (25 M). Anaphase onset is designated as time 0. Bar, 10 m. 
(C) Fluorescent intensity of EGFP-actin at the equator (x-axis) and each accumulation 
time (y-axis) were plotted in cells treated with DMSO or blebbistatin (25 M). (D) The 
average time of EGFP-actin accumulation at the equator in cells (n ≥ 5) treated with 
DMSO or blebbistatin (25 M).  
 
Figure 5. MRLC accumulation at the cell equator is independent of actin 
accumulation. 
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(A) HeLa cells treated with DMSO (control) or latrunculin A (100 nM) for 10 or 30 min 
were fixed and stained with TRITC-phalloidin. DNA was counterstained with DAPI. 
Bar, 10 m. (B) HeLa cells expressing Wt-MRLC-mCherry in the presence of DMSO 
or latrunculin A (100 nM). Anaphase onset is designated as time 0. Cells treated with 
latrunculin A exhibited remarkable blebbing, as shown in the panel at 8 min. Bar, 10 m. 
(C) Fluorescent intensity of Wt-MRLC-mCherry at the equator (x-axis) and each 
accumulation time (y-axis) were plotted in cells treated with DMSO or latrunculin A 
(100 nM). (D) The average time of Wt-MRLC-mCherry accumulation at the equator in 
cells (n ≥ 5) treated with DMSO or latrunculin A (100 nM).  
 
Figure 6. A proposed mechanism for equatorial myosin II accumulation  
Before anaphase onset, phosphorylated myosin II preferentially accumulates at the cell 
equator (a, b). This accumulation causes an increase in cortical tension by interaction 
with actin, which induces a conformational change in cortical actin (c). As a result, such 
actin filaments enhance myosin II accumulation at the cell equator (d). Subsequently, 
actin accumulation or polymerization occurs (e), followed CR constriction. P-Myosin II 
or Non-P-Myosin II indicates myosin II binding to phosphorylated or 
nonphosphorylated MRLC, respectively. 
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Supplementary Figure Caption 
 
Figure S1. Accumulation time of myosin II regulatory light chain (MRLC) and 
actin at the equator is independent of their expression levels.   
The fluorescent intensity of (A) mCherry-tagged MRLC mutants or (B) enhanced green 
fluorescent protein (EGFP)-actin at the equator (x-axis) and each accumulation time 
(y-axis) were plotted in cells coexpressing MRLC-mCherry and EGFP-actin. 
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